Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of MicroRNAs

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Chen, Wei Xian ^a,b   Liu, Xue Min ^a,b   Lv, Meng Meng ^a,b   Chen, Lin ^b,c   Zhao, Jian Hua ^b   Zhong, Shan Liang ^b   Ji, Ming Hua ^b   Hu, Qing ^b,c   Luo, Zhou ^a,b   Wu, Jian Zhong ^b   Tang, Jin Hai ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JIANGSU CANCER HOSPITAL   (China)

^c XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; DOXORUBICIN; MICRORNA; MICRORNA 100; MICRORNA 17; MICRORNA 222; MICRORNA 30A; MICRORNA 342 3P; MICRORNA 451; RIBONUCLEASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CANCER RESISTANCE; CARCINOGENESIS; CELL CYCLE REGULATION; CELL SURVIVAL; CONTROLLED STUDY; EXOSOME; GENE EXPRESSION; GENE IDENTIFICATION; GENE MAPPING; GENE TARGETING; GENETIC TRANSFECTION; HORIZONTAL GENE TRANSFER; HUMAN; HUMAN CELL; MCF 7 CELL LINE; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

EID: 84930172395     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095240     Document Type: Article

References (43)

1. Gottesman MM (2002) Mechanisms of cancer drug resistance. Annu Rev Med 53: 615-627.
2. Azmi AS, Bao B, Sarkar FH (2013) Exosomes in cancer development, metastasis, and drug resistance: A comprehensive review. Cancer Metastasis Rev 32: 623-642.
3. Simons M, Raposo G (2009) Exosomes-vesicular carriers for intercellular communication. Curr Opin Cell Biol 21: 575-581.
4. Kucharzewska P, Christianson HC, Welch JE, Svensson KJ, Fredlund E, et al. (2013) Exosomes reflect the hypoxic status of glioma cells and mediate hypoxiadependent activation of vascular cells during tumor development. Proc Natl Acad Sci U S A 110: 7312-7317.
5. Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, et al. (2012) Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 151: 1542-1556.
6. Filipazzi P, Burdek M, Villa A, Rivoltini L, Huber V (2012) Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Semin Cancer Biol 22: 342-349.
7. Kahlert C, Kalluri R (2013) Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl) 91: 431-437.
8. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, et al. (2007) Exosomemediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659.
9. Chiba M, Kimura M, Asari S (2012) Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma HepG2 and lung cancer A549 cell lines. Oncol Rep 28: 1551-1558.
10. Morel L, Regan M, Higashimori H, Ng SK, Esau C, et al. (2013) Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1. J Biol Chem 288: 7105-7116.
11. Kosaka N, Iguchi H, Ochiya T (2010) Circulating microRNA in body fluid: A new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 101: 2087-2092.
12. Knaust E, Porwit-MacDonald A, Gruber A, Xu D, Peterson C (2000) Heterogeneity of isolated mononuclear cells from patients with acute myeloid leukemia affects cellular accumulation and efflux of daunorubicin. Haematologica 85: 124-132.
13. Levchenko A, Mehta BM, Niu X, Kang G, Villafania L, et al. (2005) Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells. Proc Natl Acad Sci U S A 102: 1933-1938.
14. Li WJ, Zhong SL, Wu YJ, Xu WD, Xu JJ, et al. (2013) Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- And adriamycin-resistant breast cancer cell lines. Mol Biol Rep 40: 6143-6150.
15. Zhong S, Li W, Chen Z, Xu J, Zhao J (2013) MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells. Gene 531: 8-14.
16. Corcoran C, Rani S, O'Brien K, O'Neill A, Prencipe M, et al. (2012) Docetaxelresistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes. PLoS One 7: e50999.
17. Safaei R, Larson BJ, Cheng TC, Gibson MA, Otani S, et al. (2005) Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther 4: 1595-1604.
18. O'Brien K, Rani S, Corcoran C, Wallace R, Hughes L, et al. (2013) Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells. Eur J Cancer 49: 1845-1859.
19. Miot S, Gianni-Barrera R, Pelttari K, Acharya C, Mainil-Varlet P, et al. (2010) In vitro and in vivo validation of human and goat chondrocyte labeling by green fluorescent protein lentivirus transduction. Tissue Eng Part C Methods 16: 11- 21.
20. Fonsato V, Collino F, Herrera MB, Cavallari C, Deregibus MC, et al. (2012) Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. Stem Cells 30: 1985-1998.
21. Pasquier J, Magal P, Boulange-Lecomte C, Webb G, Le Foll F (2011) Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer: A cell population dynamics model. Biol Direct 6: 5.
22. Reis LA, Borges FT, Simões MJ, Borges AA, Sinigaglia-Coimbra R, et al. (2012) Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats. PLoS One 7: e44092.
23. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500.
24. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
25. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: Tools for microRNA genomics. Nucleic Acids Res 36: D154-D158.
26. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, et al. (2008) KEGG for linking genomes to life and the environment. Nucleic Acids Res 36: D480-D484.
27. Herve JC, Derangeon M (2013) Gap-junction-mediated cell-to-cell communication. Cell Tissue Res 352: 21-31.
28. Singer SJ (1992) Intercellular communication and cell-cell adhesion. Science 255: 1671-1677.
29. Imagawa W, Pedchenko VK, Helber J, Zhang H (2002) Hormone/growth factor interactions mediating epithelial/stromal communication in mammary gland development and carcinogenesis. J Steroid Biochem Mol Biol 80: 213- 230.
30. Hannafon BN, Ding WQ (2013) Intercellular Communication by Exosome- Derived microRNAs in Cancer. Int J Mol Sci 14: 14240-14269.
31. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Urbanowicz B, et al. (2006) Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother 55: 808-818.
32. Chen WX, Zhong SL, Ji MH, Pan M, Hu Q, et al. (2013) MicroRNAs delivered by extracellular vesicles: An emerging resistance mechanism for breast cancer. Tumour Biol.
33. Chen X, Liang H, Zhang J, Zen K, Zhang CY (2012) Secreted microRNAs: A new form of intercellular communication. Trends Cell Biol 22: 125-132.
34. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, et al. (2011) MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 8: 467-477.
35. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
36. Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, et al. (2009) Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 15: 5473-5477.
37. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, et al. (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3: e3148.
38. Yuan A, Farber EL, Rapoport AL, Tejada D, Deniskin R, et al. (2009) Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One 4: e4722.
39. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: The next generation. Cell 144: 646-674.
40. Sebolt-Leopold JS, Herrera R (2004) Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 4: 937-947.
41. Harburg GC, Hinck L (2011) Navigating breast cancer: Axon guidance molecules as breast cancer tumor suppressors and oncogenes. J Mammary Gland Biol Neoplasia 16: 257-270.
42. Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, et al. (2009) miR- 221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 16:498-509.
43. Kogure T, Lin WL, Yan IK, Braconi C, Patel T (2011) Intercellular nanovesiclemediated microRNA transfer: A mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology 54: 1237-1248.